{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:46:26Z","timestamp":1778319986825,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"S10","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The Food and Drug Administration (FDA) approved drug labels contain a broad array of information, ranging from adverse drug reactions (ADRs) to drug efficacy, risk-benefit consideration, and more. However, the labeling language used to describe these information is free text often containing ambiguous semantic descriptions, which poses a great challenge in retrieving useful information from the labeling text in a consistent and accurate fashion for comparative analysis across drugs. Consequently, this task has largely relied on the manual reading of the full text by experts, which is time consuming and labor intensive.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>In this study, a novel text mining method with unsupervised learning in nature, called topic modeling, was applied to the drug labeling with a goal of discovering \u201ctopics\u201d that group drugs with similar safety concerns and\/or therapeutic uses together. A total of 794 FDA-approved drug labels were used in this study. First, the three labeling sections (i.e., Boxed Warning, Warnings and Precautions, Adverse Reactions) of each drug label were processed by the Medical Dictionary for Regulatory Activities (MedDRA) to convert the free text of each label to the standard ADR terms. Next, the topic modeling approach with latent Dirichlet allocation (LDA) was applied to generate 100 topics, each associated with a set of drugs grouped together based on the probability analysis. Lastly, the efficacy of the topic modeling was evaluated based on known information about the therapeutic uses and safety data of drugs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The results demonstrate that drugs grouped by topics are associated with the same safety concerns and\/or therapeutic uses with statistical significance (P&lt;0.05). The identified topics have distinct context that can be directly linked to specific adverse events (e.g., liver injury or kidney injury) or therapeutic application (e.g., antiinfectives for systemic use). We were also able to identify potential adverse events that might arise from specific medications via topics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The successful application of topic modeling on the FDA drug labeling demonstrates its potential utility as a hypothesis generation means to infer hidden relationships of concepts such as, in this study, drug safety and therapeutic use in the study of biomedical documents.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2105-12-s10-s11","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T06:48:14Z","timestamp":1319179694000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Mining FDA drug labels using an unsupervised learning technique - topic modeling"],"prefix":"10.1186","volume":"12","author":[{"given":"Halil","family":"Bisgin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhichao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weida","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,18]]},"reference":[{"key":"4851_CR1","volume-title":"Modern Information Retrieval","author":"R Baeza-Yates","year":"1999","unstructured":"Baeza-Yates R, Ribeiro-Neto. B: Modern Information Retrieval. New York: ACM Press; 1999."},{"issue":"1","key":"4851_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1353\/pbm.1986.0087","volume":"30","author":"DR Swanson","year":"1986","unstructured":"Swanson DR: Fish oil, Raynaud's syndrome, and undiscovered public knowledge. Perspectives in Biology and Medicine 1986, 30(1):7\u201318.","journal-title":"Perspectives in Biology and Medicine"},{"key":"4851_CR3","volume-title":"Introduction to Modern Information Retrieval","author":"G Salton","year":"1983","unstructured":"Salton G, McGill MJ: Introduction to Modern Information Retrieval. McGraw-Hill; 1983."},{"issue":"2","key":"4851_CR4","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/(SICI)1097-4571(199602)47:2<116::AID-ASI3>3.0.CO;2-1","volume":"47","author":"MD Gordon","year":"1996","unstructured":"Gordon MD, Lindsay RK: Toward discovery support systems: a replication, re-examination, and extension of Swanson's work on literature-based discovery of a connection between Raynaud's and fish oil. J Am Soc Inf Sci 1996, 47(2):116\u2013128. 10.1002\/(SICI)1097-4571(199602)47:2<116::AID-ASI3>3.0.CO;2-1","journal-title":"J Am Soc Inf Sci"},{"issue":"6","key":"4851_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9","volume":"41","author":"S Deerwester","year":"1990","unstructured":"Deerwester S, Dumais ST, Furnas GW, Landauer TK, Harshman R: Indexing by latent semantic analysis. J Am Soc Inf Sci 1990, 41(6):391\u2013407. 10.1002\/(SICI)1097-4571(199009)41:6<391::AID-ASI1>3.0.CO;2-9","journal-title":"J Am Soc Inf Sci"},{"issue":"8","key":"4851_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/(SICI)1097-4571(199806)49:8<674::AID-ASI2>3.0.CO;2-T","volume":"49","author":"MD Gordon","year":"1998","unstructured":"Gordon MD, Dumais S: Using latent semantic indexing for literature based discovery. J Am Soc Inf Sci 1998, 49(8):674\u2013685. 10.1002\/(SICI)1097-4571(199806)49:8<674::AID-ASI2>3.0.CO;2-T","journal-title":"J Am Soc Inf Sci"},{"key":"4851_CR7","volume-title":"Proceedings of the Twenty-Second Annual International SIGIR Conference","author":"T Hofmann","year":"1999","unstructured":"Hofmann T: latent semantic indexing. Proceedings of the Twenty-Second Annual International SIGIR Conference 1999."},{"key":"4851_CR8","first-page":"993","volume-title":"J Mach Learn Res","author":"DM Blei","year":"2003","unstructured":"Blei DM, Ng AY, Jordan MI: Latent Dirichlet Allocation. In J Mach Learn Res. Volume 3. Cambridge, MA: MIT Press; 2003:993\u20131022."},{"issue":"1","key":"4851_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1214\/07-AOAS114","volume":"1","author":"DM Blei","year":"2007","unstructured":"Blei DM, Lafferty JD: A correlated topic model of science. Annals of Applied Statistics 2007, 1(1):17\u201335. 10.1214\/07-AOAS114","journal-title":"Annals of Applied Statistics"},{"key":"4851_CR10","volume-title":"Plos One","author":"HJ Wang","year":"2011","unstructured":"Wang HJ, Ding Y, Tang J, Dong XA, He B, Qiu J, Wild DJ: Finding Complex Biological Relationships in Recent PubMed Articles Using Bio-LDA. Plos One 2011., 6(3):"},{"key":"4851_CR11","volume-title":"BMC Bioinformatics","author":"B Zheng","year":"2006","unstructured":"Zheng B, McLean DC, Lu XH: Identifying biological concepts from a protein-related corpus with a probabilistic topic model. BMC Bioinformatics 2006., 7:"},{"key":"4851_CR12","first-page":"954","volume-title":"Vegas, Nevada, USA: ACM","author":"FDM Morchen","year":"2008","unstructured":"Morchen FDM, Fradkin D, Etienne J, Wachmann B, et al.: Anticipating annotations and emerging trends in biomedical literature. Vegas, Nevada, USA: ACM 2008, 954\u2013962."},{"key":"4851_CR13","first-page":"6","volume":"11","author":"CB Ahlers","year":"2007","unstructured":"Ahlers CB, Hristovski D, Kilicoglu H, Rindflesch TC: Using the literature-based discovery paradigm to investigate drug mechanisms. AMIA Annual Symposium Proceedings 2007, 11: 6\u201310.","journal-title":"AMIA Annual Symposium Proceedings"},{"issue":"6","key":"4851_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF01870611","volume":"17","author":"F Rikken","year":"1995","unstructured":"Rikken F, Vos R: How adverse drug reactions can play a role in innovative drug research. Pharm World Sci 1995, 17(6):195\u2013200. 10.1007\/BF01870611","journal-title":"Pharm World Sci"},{"key":"4851_CR15","volume-title":"Adverse Reactions Section of Labeling for Human Prescription Drug and Biological Products \u2014 Content and Format.","author":"CDER","year":"2006b","unstructured":"CDER: Adverse Reactions Section of Labeling for Human Prescription Drug and Biological Products \u2014 Content and Format. . 2006b. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm075057.pdf"},{"key":"4851_CR16","volume-title":"Labeling for Human Prescription Drug and Biological Products \u2014 Implementing the New Content and Format Requirements.","author":"CDER","year":"2006a","unstructured":"CDER: Labeling for Human Prescription Drug and Biological Products \u2014 Implementing the New Content and Format Requirements. . 2006a. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm075082.pdf"},{"key":"4851_CR17","volume-title":"Warnings and Precautions, Contraindications, and Boxed Warning Sections of Labeling for Human Prescription Drug and Biological Products \u2014 Content and Format.","author":"CDER","year":"2006c","unstructured":"CDER: Warnings and Precautions, Contraindications, and Boxed Warning Sections of Labeling for Human Prescription Drug and Biological Products \u2014 Content and Format. . 2006c. http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm075096.pdf"},{"key":"4851_CR18","unstructured":"Chen MJ, Vijay V, Shi Q, Liu ZC, Fang H, Tong WD: Using FDA-approved drug labeling to develop a benchmark drug list for the study of drug-induced liver injury. Drug Discovery Today, in press."},{"issue":"4","key":"4851_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/pds.856","volume":"13","author":"ME Willy","year":"2004","unstructured":"Willy ME, Li ZL: What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling. Pharmacoepidemiology and Drug Safety 2004, 13(4):201\u2013206. 10.1002\/pds.856","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"3","key":"4851_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/ACO.0b013e328338c9f7","volume":"23","author":"K Halloran","year":"2010","unstructured":"Halloran K, Barash PG: Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system. Current Opinion in Anesthesiology 2010, 23(3):423\u2013427. 10.1097\/ACO.0b013e328338c9f7","journal-title":"Current Opinion in Anesthesiology"},{"issue":"17","key":"4851_CR21","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1001\/jama.287.17.2215","volume":"287","author":"KE Lasser","year":"2002","unstructured":"Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SN, Bor DH: Timing of new black box warnings and withdrawals for prescription medications. Journal of the American Medical Association 2002, 287(17):2215\u20132220. 10.1001\/jama.287.17.2215","journal-title":"Journal of the American Medical Association"},{"issue":"9","key":"4851_CR22","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1021\/jm801546k","volume":"52","author":"J Scheiber","year":"2009","unstructured":"Scheiber J, Jenkins JL, Sukuru SCK, Bender A, Mikhailov D, Milik M, Azzaoui K, Whitebread S, Hamon J, Urban L, et al.: Mapping Adverse Drug Reactions in Chemical Space. Journal of Medicinal Chemistry 2009, 52(9):3103\u20133107. 10.1021\/jm801546k","journal-title":"Journal of Medicinal Chemistry"},{"key":"4851_CR23","volume-title":"\"MALLET: A Machine Learning for Language Toolkit.\"","author":"AK McCallum","year":"2002","unstructured":"McCallum AK: \"MALLET: A Machine Learning for Language Toolkit.\".2002. [http:\/\/mallet.cs.umass.edu\/]"},{"issue":"1","key":"4851_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaci.2005.10.031","volume":"117","author":"S Murphy","year":"2006","unstructured":"Murphy S, Roberts R: \"Black box\" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit\/risk. Journal of Allergy and Clinical Immunology 2006, 117(1):34\u201339. 10.1016\/j.jaci.2005.10.031","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9","key":"4851_CR25","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0011-393X(01)80070-9","volume":"62","author":"AE Trontell","year":"2001","unstructured":"Trontell AE: How the US Food and Drug Administration defines and detects adverse drug events. Current Therapeutic Research-Clinical and Experimental 2001, 62(9):641\u2013649. 10.1016\/S0011-393X(01)80070-9","journal-title":"Current Therapeutic Research-Clinical and Experimental"},{"key":"4851_CR26","unstructured":"[http:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?id=5558]"},{"issue":"1","key":"4851_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/nar\/30.1.52","volume":"30","author":"A Hamosh","year":"2002","unstructured":"Hamosh A, Scott AF, Amberger J, Bocchini C, Valle D, McKusick VA: Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Research 2002, 30(1):52\u201355. 10.1093\/nar\/30.1.52","journal-title":"Nucleic Acids Research"},{"key":"4851_CR28","doi-asserted-by":"publisher","first-page":"D514","DOI":"10.1093\/nar\/gki033","volume":"33","author":"A Hamosh","year":"2005","unstructured":"Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA: Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Research 2005, 33: D514-D517.","journal-title":"Nucleic Acids Research"},{"key":"4851_CR29","volume-title":"BMC Bioinformatics","author":"M Bundschus","year":"2008","unstructured":"Bundschus M, Dejori M, Stetter M, Tresp V, Kriegel HP: Extraction of semantic biomedical relations from text using conditional random fields. BMC Bioinformatics 2008., 9:"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-12-S10-S11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T16:39:49Z","timestamp":1630514389000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-12-S10-S11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,18]]},"references-count":29,"journal-issue":{"issue":"S10","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["4851"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-12-s10-s11","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,18]]},"assertion":[{"value":"18 October 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"S11"}}